R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Q1 Clinical trials round-up: Jan-Mar 2025

The first quarter of 2025 saw a wave of significant advancements in clinical research across oncology, neurology, dermatology, respiratory, and rare diseases.

R&D

graphic illustration of liver within human body on abstract background with DNA chain

Navigating the complexities of drug development in hepatolog...

In the realm of medical research, liver disease remains a complex and often overlooked field.

R&D

For cell therapies, raw material quality hinges on the human...

When it comes to cell-based therapy manufacturing, the concept of quality management carries important distinctions from more traditional therapeutics production.

R&D

female researchers looking at results on a computer screen

Driving innovation and improving patient outcomes through in...

Achieving diversity and inclusion in medical research is essential for advancing healthcare, discovering novel drug therapies, and achieving overall health equity.

R&D

Shifting paradigms of clinical trial design accelerate CNS R...

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed.

R&D